Global and Japan Chronic Idiopathic Constipation Drugs Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 30-Nov-2020
No. of pages: 126
Inquire Before Buying

Global Chronic Idiopathic Constipation Drugs Scope and Market Size

Chronic Idiopathic Constipation Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Idiopathic Constipation Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Linaclotide

- Lubiprostone

- Other

Market segment by Application, split into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Based on regional and country-level analysis, the Chronic Idiopathic Constipation Drugs market has been segmented as follows:

- North America

- United States

- Canada

- Europe

- Germany

- France

- U.K.

- Italy

- Russia

- Nordic

- Rest of Europe

- Asia-Pacific

- China

- Japan

- South Korea

- Southeast Asia

- India

- Australia

- Rest of Asia-Pacific

- Latin America

- Mexico

- Brazil

- Middle East & Africa

- Turkey

- Saudi Arabia

- UAE

- Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Chronic Idiopathic Constipation Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Pfizer

- Glaxosmithkline

- Roche Holding AG

- Sanofi

- Bayer AG

- Merck

- Eli Lilly

- Allergens

- Chugai Pharmaceutical

- Ferring International Center S.A

- Synergy Pharmaceuticals

- Salix Pharmaceuticals Ltd

- Sucampo Pharmaceuticals Inc

- Ironwood Pharmaceuticals Inc

- Bausch Health

- Daiichi Sankyo

- Cosmo Pharmaceuticals SA

- Progenics Pharmaceuticals Inc

- Theravance Biopharma Inc

Global and Japan Chronic Idiopathic Constipation Drugs Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Idiopathic Constipation Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Linaclotide
1.2.3 Lubiprostone
1.2.4 Other
1.3 Market by Application
1.3.1 Global Chronic Idiopathic Constipation Drugs Market Share by Application: 2020 VS 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Idiopathic Constipation Drugs Market Perspective (2015-2026)
2.2 Global Chronic Idiopathic Constipation Drugs Growth Trends by Regions
2.2.1 Chronic Idiopathic Constipation Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Idiopathic Constipation Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Idiopathic Constipation Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Idiopathic Constipation Drugs Players by Market Size
3.1.1 Global Top Chronic Idiopathic Constipation Drugs Players by Revenue (2015-2020)
3.1.2 Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Chronic Idiopathic Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Idiopathic Constipation Drugs Revenue
3.4 Global Chronic Idiopathic Constipation Drugs Market Concentration Ratio
3.4.1 Global Chronic Idiopathic Constipation Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation Drugs Revenue in 2019
3.5 Key Players Chronic Idiopathic Constipation Drugs Area Served
3.6 Key Players Chronic Idiopathic Constipation Drugs Product Solution and Service
3.7 Date of Enter into Chronic Idiopathic Constipation Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Idiopathic Constipation Drugs Breakdown Data by Type (2015-2026)
4.1 Global Chronic Idiopathic Constipation Drugs Historic Market Size by Type (2015-2020)
4.2 Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Type (2021-2026)
5 Chronic Idiopathic Constipation Drugs Breakdown Data by Application (2015-2026)
5.1 Global Chronic Idiopathic Constipation Drugs Historic Market Size by Application (2015-2020)
5.2 Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chronic Idiopathic Constipation Drugs Market Size (2015-2026)
6.2 North America Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020)
6.3 North America Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020)
6.4 North America Chronic Idiopathic Constipation Drugs Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Chronic Idiopathic Constipation Drugs Market Size (2015-2026)
7.2 Europe Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020)
7.3 Europe Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020)
7.4 Europe Chronic Idiopathic Constipation Drugs Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Chronic Idiopathic Constipation Drugs Market Size (2015-2026)
8.2 China Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020)
8.3 China Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020)
8.4 China Chronic Idiopathic Constipation Drugs Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Chronic Idiopathic Constipation Drugs Market Size (2015-2026)
9.2 Japan Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020)
9.3 Japan Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020)
9.4 Japan Chronic Idiopathic Constipation Drugs Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (2015-2026)
10.2 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Chronic Idiopathic Constipation Drugs Introduction
11.1.4 Pfizer Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020))
11.1.5 Pfizer Recent Development
11.2 Glaxosmithkline
11.2.1 Glaxosmithkline Company Details
11.2.2 Glaxosmithkline Business Overview
11.2.3 Glaxosmithkline Chronic Idiopathic Constipation Drugs Introduction
11.2.4 Glaxosmithkline Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
11.2.5 Glaxosmithkline Recent Development
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Details
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Chronic Idiopathic Constipation Drugs Introduction
11.3.4 Roche Holding AG Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
11.3.5 Roche Holding AG Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Chronic Idiopathic Constipation Drugs Introduction
11.4.4 Sanofi Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
11.4.5 Sanofi Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Chronic Idiopathic Constipation Drugs Introduction
11.5.4 Bayer AG Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
11.5.5 Bayer AG Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Chronic Idiopathic Constipation Drugs Introduction
11.6.4 Merck Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
11.6.5 Merck Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Chronic Idiopathic Constipation Drugs Introduction
11.7.4 Eli Lilly Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
11.7.5 Eli Lilly Recent Development
11.8 Allergens
11.8.1 Allergens Company Details
11.8.2 Allergens Business Overview
11.8.3 Allergens Chronic Idiopathic Constipation Drugs Introduction
11.8.4 Allergens Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
11.8.5 Allergens Recent Development
11.9 Chugai Pharmaceutical
11.9.1 Chugai Pharmaceutical Company Details
11.9.2 Chugai Pharmaceutical Business Overview
11.9.3 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Introduction
11.9.4 Chugai Pharmaceutical Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
11.9.5 Chugai Pharmaceutical Recent Development
11.10 Ferring International Center S.A
11.10.1 Ferring International Center S.A Company Details
11.10.2 Ferring International Center S.A Business Overview
11.10.3 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Introduction
11.10.4 Ferring International Center S.A Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
11.10.5 Ferring International Center S.A Recent Development
11.11 Synergy Pharmaceuticals
10.11.1 Synergy Pharmaceuticals Company Details
10.11.2 Synergy Pharmaceuticals Business Overview
10.11.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Introduction
10.11.4 Synergy Pharmaceuticals Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
10.11.5 Synergy Pharmaceuticals Recent Development
11.12 Salix Pharmaceuticals Ltd
10.12.1 Salix Pharmaceuticals Ltd Company Details
10.12.2 Salix Pharmaceuticals Ltd Business Overview
10.12.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Introduction
10.12.4 Salix Pharmaceuticals Ltd Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
10.12.5 Salix Pharmaceuticals Ltd Recent Development
11.13 Sucampo Pharmaceuticals Inc
10.13.1 Sucampo Pharmaceuticals Inc Company Details
10.13.2 Sucampo Pharmaceuticals Inc Business Overview
10.13.3 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Introduction
10.13.4 Sucampo Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
10.13.5 Sucampo Pharmaceuticals Inc Recent Development
11.14 Ironwood Pharmaceuticals Inc
10.14.1 Ironwood Pharmaceuticals Inc Company Details
10.14.2 Ironwood Pharmaceuticals Inc Business Overview
10.14.3 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Introduction
10.14.4 Ironwood Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
10.14.5 Ironwood Pharmaceuticals Inc Recent Development
11.15 Bausch Health
10.15.1 Bausch Health Company Details
10.15.2 Bausch Health Business Overview
10.15.3 Bausch Health Chronic Idiopathic Constipation Drugs Introduction
10.15.4 Bausch Health Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
10.15.5 Bausch Health Recent Development
11.16 Daiichi Sankyo
10.16.1 Daiichi Sankyo Company Details
10.16.2 Daiichi Sankyo Business Overview
10.16.3 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Introduction
10.16.4 Daiichi Sankyo Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
10.16.5 Daiichi Sankyo Recent Development
11.17 Cosmo Pharmaceuticals SA
10.17.1 Cosmo Pharmaceuticals SA Company Details
10.17.2 Cosmo Pharmaceuticals SA Business Overview
10.17.3 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Introduction
10.17.4 Cosmo Pharmaceuticals SA Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
10.17.5 Cosmo Pharmaceuticals SA Recent Development
11.18 Progenics Pharmaceuticals Inc
10.18.1 Progenics Pharmaceuticals Inc Company Details
10.18.2 Progenics Pharmaceuticals Inc Business Overview
10.18.3 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Introduction
10.18.4 Progenics Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
10.18.5 Progenics Pharmaceuticals Inc Recent Development
11.19 Theravance Biopharma Inc
10.19.1 Theravance Biopharma Inc Company Details
10.19.2 Theravance Biopharma Inc Business Overview
10.19.3 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Introduction
10.19.4 Theravance Biopharma Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020)
10.19.5 Theravance Biopharma Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Chronic Idiopathic Constipation Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Linaclotide
Table 4. Key Players of Lubiprostone
Table 5. Key Players of Other
Table 6. Global Chronic Idiopathic Constipation Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Chronic Idiopathic Constipation Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Chronic Idiopathic Constipation Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Chronic Idiopathic Constipation Drugs Market Share by Regions (2015-2020)
Table 10. Global Chronic Idiopathic Constipation Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Chronic Idiopathic Constipation Drugs Market Share by Regions (2021-2026)
Table 12. Chronic Idiopathic Constipation Drugs Market Market Trends
Table 13. Chronic Idiopathic Constipation Drugs Market Drivers
Table 14. Chronic Idiopathic Constipation Drugs Market Challenges
Table 15. Chronic Idiopathic Constipation Drugs Market Restraints
Table 16. Global Chronic Idiopathic Constipation Drugs Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Chronic Idiopathic Constipation Drugs Market Share by Players (2015-2020)
Table 18. Global Top Chronic Idiopathic Constipation Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Constipation Drugs as of 2019)
Table 19. Global Chronic Idiopathic Constipation Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Idiopathic Constipation Drugs Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Chronic Idiopathic Constipation Drugs Market Size Share by Type (2015-2020)
Table 25. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2021-2026)
Table 26. Global Chronic Idiopathic Constipation Drugs Market Size Share by Application (2015-2020)
Table 27. Global Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Chronic Idiopathic Constipation Drugs Market Size Share by Application (2021-2026)
Table 29. North America Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Chronic Idiopathic Constipation Drugs Market Share by Type (2015-2020)
Table 31. North America Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Chronic Idiopathic Constipation Drugs Market Share by Application (2015-2020)
Table 33. North America Chronic Idiopathic Constipation Drugs Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Chronic Idiopathic Constipation Drugs Market Share by Country (2015-2020)
Table 35. Europe Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Chronic Idiopathic Constipation Drugs Market Share by Type (2015-2020)
Table 37. Europe Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Chronic Idiopathic Constipation Drugs Market Share by Application (2015-2020)
Table 39. Europe Chronic Idiopathic Constipation Drugs Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Chronic Idiopathic Constipation Drugs Market Share by Country (2015-2020)
Table 41. China Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020) (US$ Million)
Table 42. China Chronic Idiopathic Constipation Drugs Market Share by Type (2015-2020)
Table 43. China Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020) (US$ Million)
Table 44. China Chronic Idiopathic Constipation Drugs Market Share by Application (2015-2020)
Table 45. China Chronic Idiopathic Constipation Drugs Market Size by Region (US$ Million) (2015-2020)
Table 46. China Chronic Idiopathic Constipation Drugs Market Share by Region (2015-2020)
Table 47. Japan Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Chronic Idiopathic Constipation Drugs Market Share by Type (2015-2020)
Table 49. Japan Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Chronic Idiopathic Constipation Drugs Market Share by Application (2015-2020)
Table 51. Japan Chronic Idiopathic Constipation Drugs Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Chronic Idiopathic Constipation Drugs Market Share by Country (2015-2020)
Table 53. Southeast Asia Chronic Idiopathic Constipation Drugs Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Chronic Idiopathic Constipation Drugs Market Share by Type (2015-2020)
Table 55. Southeast Asia Chronic Idiopathic Constipation Drugs Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Chronic Idiopathic Constipation Drugs Market Share by Application (2015-2020)
Table 57. Southeast Asia Chronic Idiopathic Constipation Drugs Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Chronic Idiopathic Constipation Drugs Market Share by Country (2015-2020)
Table 59. Pfizer Company Details
Table 60. Pfizer Business Overview
Table 61. Pfizer Product
Table 62. Pfizer Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Glaxosmithkline Company Details
Table 65. Glaxosmithkline Business Overview
Table 66. Glaxosmithkline Product
Table 67. Glaxosmithkline Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 68. Glaxosmithkline Recent Development
Table 69. Roche Holding AG Company Details
Table 70. Roche Holding AG Business Overview
Table 71. Roche Holding AG Product
Table 72. Roche Holding AG Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 73. Roche Holding AG Recent Development
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Product
Table 77. Sanofi Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Bayer AG Company Details
Table 80. Bayer AG Business Overview
Table 81. Bayer AG Product
Table 82. Bayer AG Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 83. Bayer AG Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Product
Table 87. Merck Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 88. Merck Recent Development
Table 89. Eli Lilly Company Details
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Product
Table 92. Eli Lilly Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 93. Eli Lilly Recent Development
Table 94. Allergens Business Overview
Table 95. Allergens Product
Table 96. Allergens Company Details
Table 97. Allergens Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 98. Allergens Recent Development
Table 99. Chugai Pharmaceutical Company Details
Table 100. Chugai Pharmaceutical Business Overview
Table 101. Chugai Pharmaceutical Product
Table 102. Chugai Pharmaceutical Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 103. Chugai Pharmaceutical Recent Development
Table 104. Ferring International Center S.A Company Details
Table 105. Ferring International Center S.A Business Overview
Table 106. Ferring International Center S.A Product
Table 107. Ferring International Center S.A Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 108. Ferring International Center S.A Recent Development
Table 109. Synergy Pharmaceuticals Company Details
Table 110. Synergy Pharmaceuticals Business Overview
Table 111. Synergy Pharmaceuticals Product
Table 112. Synergy Pharmaceuticals Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 113. Synergy Pharmaceuticals Recent Development
Table 114. Salix Pharmaceuticals Ltd Company Details
Table 115. Salix Pharmaceuticals Ltd Business Overview
Table 116. Salix Pharmaceuticals Ltd Product
Table 117. Salix Pharmaceuticals Ltd Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 118. Salix Pharmaceuticals Ltd Recent Development
Table 119. Sucampo Pharmaceuticals Inc Company Details
Table 120. Sucampo Pharmaceuticals Inc Business Overview
Table 121. Sucampo Pharmaceuticals Inc Product
Table 122. Sucampo Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 123. Sucampo Pharmaceuticals Inc Recent Development
Table 124. Ironwood Pharmaceuticals Inc Company Details
Table 125. Ironwood Pharmaceuticals Inc Business Overview
Table 126. Ironwood Pharmaceuticals Inc Product
Table 127. Ironwood Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 128. Ironwood Pharmaceuticals Inc Recent Development
Table 129. Bausch Health Company Details
Table 130. Bausch Health Business Overview
Table 131. Bausch Health Product
Table 132. Bausch Health Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 133. Bausch Health Recent Development
Table 134. Daiichi Sankyo Company Details
Table 135. Daiichi Sankyo Business Overview
Table 136. Daiichi Sankyo Product
Table 137. Daiichi Sankyo Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 138. Daiichi Sankyo Recent Development
Table 139. Cosmo Pharmaceuticals SA Company Details
Table 140. Cosmo Pharmaceuticals SA Business Overview
Table 141. Cosmo Pharmaceuticals SA Product
Table 142. Cosmo Pharmaceuticals SA Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 143. Cosmo Pharmaceuticals SA Recent Development
Table 144. Progenics Pharmaceuticals Inc Company Details
Table 145. Progenics Pharmaceuticals Inc Business Overview
Table 146. Progenics Pharmaceuticals Inc Product
Table 147. Progenics Pharmaceuticals Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 148. Progenics Pharmaceuticals Inc Recent Development
Table 149. Theravance Biopharma Inc Company Details
Table 150. Theravance Biopharma Inc Business Overview
Table 151. Theravance Biopharma Inc Product
Table 152. Theravance Biopharma Inc Revenue in Chronic Idiopathic Constipation Drugs Business (2015-2020) (US$ Million)
Table 153. Theravance Biopharma Inc Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Idiopathic Constipation Drugs Market Share by Type: 2020 VS 2026
Figure 2. Linaclotide Features
Figure 3. Lubiprostone Features
Figure 4. Other Features
Figure 5. Global Chronic Idiopathic Constipation Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Chronic Idiopathic Constipation Drugs Report Years Considered
Figure 10. Global Chronic Idiopathic Constipation Drugs Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Chronic Idiopathic Constipation Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Chronic Idiopathic Constipation Drugs Market Share by Regions (2021-2026)
Figure 13. Global Chronic Idiopathic Constipation Drugs Market Share by Players in 2019
Figure 14. Global Top Chronic Idiopathic Constipation Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Constipation Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Chronic Idiopathic Constipation Drugs Revenue in 2019
Figure 16. North America Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Chronic Idiopathic Constipation Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Pfizer Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 44. Glaxosmithkline Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 45. Roche Holding AG Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 46. Sanofi Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 47. Bayer AG Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 48. Merck Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 49. Eli Lilly Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 50. Allergens Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 51. Chugai Pharmaceutical Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 52. Ferring International Center S.A Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 53. Synergy Pharmaceuticals Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 54. Salix Pharmaceuticals Ltd Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 55. Sucampo Pharmaceuticals Inc Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 56. Ironwood Pharmaceuticals Inc Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 57. Bausch Health Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 58. Daiichi Sankyo Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 59. Cosmo Pharmaceuticals SA Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 60. Progenics Pharmaceuticals Inc Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 61. Theravance Biopharma Inc Revenue Growth Rate in Chronic Idiopathic Constipation Drugs Business (2015-2020)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Centralized Patient Monitoring System Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 130
    According to this latest study, the 2020 growth of Centralized Patient Monitoring System will have significant change from previous year. By the most conservative estimates of global Centralized Patient Monitoring System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 490.5 million in 2019. Over the next five years the Centralized Patient Monitoring System market will register a 6.3% CAGR in terms of revenue, the global market size will rea......
  • Global Livestock Animal Vaccines Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 159
    According to this latest study, the 2020 growth of Livestock Animal Vaccines will have significant change from previous year. By the most conservative estimates of global Livestock Animal Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 4632.4 million in 2019. Over the next five years the Livestock Animal Vaccines market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 5868.7 million by 2025.......
  • Global Clinical Reference Laboratory Services Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Clinical Reference Laboratory Services will have significant change from previous year. By the most conservative estimates of global Clinical Reference Laboratory Services market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 11450 million in 2019. Over the next five years the Clinical Reference Laboratory Services market will register a 5.4% CAGR in terms of revenue, the global market size will ......
  • Global Steam Chemical Indicator Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 139
    According to this latest study, the 2020 growth of Steam Chemical Indicator will have significant change from previous year. By the most conservative estimates of global Steam Chemical Indicator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 105.9 million in 2019. Over the next five years the Steam Chemical Indicator market will register a 6.7% CAGR in terms of revenue, the global market size will reach US$ 137.2 million by 2025. ......
  • Global Oral Guided Bone Regeneration (GTR) Membrane Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 167
    According to this latest study, the 2020 growth of Oral Guided Bone Regeneration (GTR) Membrane will have significant change from previous year. By the most conservative estimates of global Oral Guided Bone Regeneration (GTR) Membrane market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 201.6 million in 2019. Over the next five years the Oral Guided Bone Regeneration (GTR) Membrane market will register a 6.6% CAGR in terms of revenue, the global......
  • Global Non-Wearable Sleep Tracker Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 137
    According to this latest study, the 2020 growth of Non-Wearable Sleep Tracker will have significant change from previous year. By the most conservative estimates of global Non-Wearable Sleep Tracker market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 250.4 million in 2019. Over the next five years the Non-Wearable Sleep Tracker market will register a 13.7% CAGR in terms of revenue, the global market size will reach US$ 418.6 million by 2025.......
  • Global Hematopoietic Stem Cells Transplantation Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 119
    According to this latest study, the 2020 growth of Hematopoietic Stem Cells Transplantation will have significant change from previous year. By the most conservative estimates of global Hematopoietic Stem Cells Transplantation market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2110.6 million in 2019. Over the next five years the Hematopoietic Stem Cells Transplantation market will register a 5.9% CAGR in terms of revenue, the global market siz......
  • Global Non-invasive Glucose Monitoring Device Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Non-invasive Glucose Monitoring Device will have significant change from previous year. By the most conservative estimates of global Non-invasive Glucose Monitoring Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2974.9 million in 2019. Over the next five years the Non-invasive Glucose Monitoring Device market will register a 26.7% CAGR in terms of revenue, the global market size wil......
  • Global Veterinary Rapid Test Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 131
    According to this latest study, the 2020 growth of Veterinary Rapid Test will have significant change from previous year. By the most conservative estimates of global Veterinary Rapid Test market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 493.7 million in 2019. Over the next five years the Veterinary Rapid Test market will register a 8.8% CAGR in terms of revenue, the global market size will reach US$ 692.3 million by 2025. Thi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs